• Porphyrio® integrates into Precision Livestock Farming

Dubai, United Arab Emirates. Evonik Animal Nutrition is launching its Precision Livestock Farming tool, Porphyrio®, for the animal nutrition industry in the Middle East at VIV MEA.

Porphyrio® uses ‘Big Data’ from the entire poultry production chain to support integrators and farmers in optimizing their production process. With this software and others, Evonik is placing its emphasis on Precision Livestock Farming (PLF) which adds advanced technologies and software to the farming process, with the goal of optimizing the contribution per animal.

“Precision Livestock Farming is poised to revolutionize the feed industry because it gives animal farms full control over the feeding process and the performance of the livestock. With Porphyrio®, producers can know in real time the progress of livestock, enabling them to find and rectify any deviations immediately,” said Ashraf Hussein, Regional Business Director at Evonik Animal Nutrition in MENA.

PLF goes beyond just gathering data. It combines science-based know-how with proven amino services, and innovative nutritional and health concepts. These are all embedded into specific digital solutions allowing for a better understanding of the status of the animal.

Evonik Animal Nutrition experts will be present in VIV Abu Dhabi with in-depth information about PLF and Porphyrio® at booth C044 at Hall 7 in the Abu Dhabi National Exhibition Center (ADNEC) between the 9th and 11th March 2020.

-Ends-

Company information

Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations.

For more information about Evonik in the Middle East and Africa, please visit https://mea.evonik.com/ 

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.